Glandokort®
Influence of GLANDOKORT® on the level of adrenal hormones in patients with ТTable 1
chronic adrenal cortex insufficiency
Indicator Norm Before treatment After treatment with After treatment with
conventional methods Glandokort®
Aldosterone in blood plasma, (pg/ml) 7,5-150 14,7±1,2 26,2±1,6 38,5±1,3*,**
17-ketosteroids common in urine, 17-70 19,8±1,6 38,2±2,4 46,3±2,1*
(μmol/day)
* p <0.05 - significant in comparison with the indicators before treatment;
** p <0.05 - significant in comparison with the indicators in the control group.
Patients with chronic adrenal cortex insufficiency, taking GLANDOKORT®, showed positive results.
There was a restoration of the metabolic activity of the reticular adrenal zone, accompanied by an in-
crease in the production of aldosterone and 17-ketosteroids, the content of which increased to the
average values of the norm (Table 1).
Effect of GLANDOKORT® on plasma levels of cortisol and adrenocorticotropic
hormone in subjects exposed to prolonged occupational or psycho-emotional stress. Table 2
Indicator Norm Before Treatment After treatment with After treatment with
conventional methods Glandokort®
Cortisol (nmol/L) 250-750 287,5±18,5 311,4±21,4 431,4±25,7*,**
ACTH (pg/ml) 10-80 14,2±1,1 17,4±1,3 28,6±1,1
* p<0.05 - significant in comparison with the indicators before treatment.
The use of GLANDOKORT® in persons exposed to prolonged exposure to professional or
psycho-emotional stress contributed to stabilizing the hormonal status, which indicates the
leveling of maladjustment disorders and catabolic reactions (Table 2). The content of cortisol and
adrenocorticotropic hormone (ACTH) before the start of treatment was noted at the lower limit of
the norm, which indicated the depletion of the reserves of the adrenal cortex—after complex therapy
using GLANDOKORT®, the level of cortisol and ATKG in the blood plasma returned to normal. These
changes were correlated with improvements in subjective scores.
No side effects, complications, or drug dependence were identified when using GLANDOKORT®.
CONCLUSION
Biologically active food supplement GLANDOKORT®has a normalizing effect on the functional activity
of adrenal cortex cells.
GLANDOKORT® is well tolerated when taken orally, has no side effects, and can be used as a
therapeutic and prophylactic biologically active food supplement.
GLANDOKORT® is recommended for use orally with meals, 1-2 capsules two times a day for 30 days,
for patients with impaired adrenal cortex function or prolonged exposure to professional or psycho-
emotional stress.
It is recommended to repeat the course in 3-6 months.
REFERENCES:
1. Belousov Y.B., Moiseev V.S., Lepakhin V.K. Clinical Pharmacology and Pharmacotherapy: A Guide
for Physicians. - M .: the Universe, 1993 .-- 398 p.
2. Mashkovsky M.D., Medicines: Pharmacotherapy for doctors, manual: 2 parts. – Vilnius: ZAO “Gamta”,
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.